SMA Europe

SMA Europe

PATIENTS ADVANCING RESEARCH

Patient-driven initiatives and actions to foster rare disease research SMA Europe has a yearly call for projects and has raised  €3 million for research. Patient organisations are making  a difference!  PHASE 1 CLINICAL TRIAL FOR SMN GENE  THERAPY START DATE ANNOUNCED Phase I Clinical Trial of Systemic SMN Gene Therapy For Spinal Muscular Atrophy will start at Nationwide Children’s Hospital in Columbus, Ohio, in… CTP Fund Announcement SMA EUROPE ANNOUNCES LAUNCH OF €200,000 CLINICAL TRIALS PREPARATION FUND. This €200,000 Fund, which is in addition to the Annual Research Call, will be available for projects that speed up the… Results of the Call for SMA Research Projects 2013 SMA Europe is pleased to announce the results of the 6th Call for research proposals. Three outstanding research projects were selected for funding: 2